Acquired JAK2 mutations confer resistance to JAK inhibitors in cell models of acute lymphoblastic leukemiaCharlotte E. J. Downes(South Australian Health and Medical Research Institute), Deborah L. White(ANZCHOG)npj Precision OncologyAugust 10, 202110.1038/s41698-021-00215-xCited by 23SaveCiteExport RISWatch citationsRelated PapersGain of chromosome 21 increases the propensity for P2RY8::CRLF2 acute lymphoblastic leukemia via increased HMGN1 expression|Frontiers in Oncology|2023|8